Are we seeing any breakthroughs in the treatment of AML?
Venetoclax in combination with low-dose cytarabine – a promising regimen for the treatment of AML
Celebrating 60 years of successful allogenic transplant at EHA 2017
How molecular testing guides treatment in AML
How can the study of familial leukemias help us to understand sporadic leukemias?
Jane E. Churpek